Frank Kung

Frank Kung

Director/Board Member chez AMYRIS, INC.

Fortune : - $ au 31/03/2024

75 ans
Health Technology
Commercial Services
Finance

Profil

Dr. Kung is a founding member of Vivo Capital, LLC (formerly BioAsia Investments), a healthcare/biotechnology venture capital management firm in Palo Alto, California.
Dr. Kung started his career in the biotechnology industry in 1979 when he joined Cetus Corporation.
He later co-founded Cetus Immune Corporation in 1981, which was acquired by its parent company in 1983.
In 1983 he co-founded Genelabs Technologies, Inc. (NADSAQ: GNLB) where he served as Chairman and CEO until 1995.
During his tenure in Genelabs, he brought the company public in 1991, and built it to a 175 employee international biotech company with operations in the United States, Belgium, Singapore, Switzerland and Taiwan.
Dr. Kung received his B.S.
in chemistry from the National Tsing Hua University in Taiwan, his Ph.D.
in molecular biology and M.B.A.
from the University of California, Berkeley.
He received the Best Use of Technology Award from the Governor of California, the Entrepreneur of the Year Awards from Ernst and Young, and the Asian Business League.
He also served on the board of directors of the Emerging Company Governing Body of the Biotechnology Industry Organization (BIO); Mt.
Jade Science and Technology Association, West Coast; and the Asian American Manufacturing Association.
He was appointed by the U.S.
Secretary of Health and Human Services as a voting member of the National Biotechnology Policy Board.
Dr. Kung currently serves on the board of directors of a number of emerging healthcare and biotechnology companies.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/03/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Frank Kung

SociétésPosteDébut
SAGENT PHARMACEUTICALS INC Director/Board Member -
AMYRIS, INC. Director/Board Member 02/11/2017
Founder 01/01/1996
Director/Board Member 01/10/2013
Director/Board Member -
Chairman -
Vivo Co-Invest (S) LP Director/Board Member -
Tous les postes actifs de Frank Kung

Anciens postes connus de Frank Kung

SociétésPosteFin
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED Director/Board Member 12/03/2022
REVANCE THERAPEUTICS, INC. Director/Board Member 08/10/2013
░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Frank Kung

Formation de Frank Kung

University of California, Berkeley Doctorate Degree
National Tsing-Hua University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Frank Kung

Relations

100 +

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
AMYRIS, INC.

Process Industries

REVANCE THERAPEUTICS, INC.

Health Technology

NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.

Health Technology

TOT BIOPHARM INTERNATIONAL COMPANY LIMITED

Health Technology

Entreprise privées16

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Cetus Corp.

Health Technology

Finance

Health Technology

Asian American Manufacturers Association

Commercial Services

Health Services

Vivo Co-Invest (S) LP

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Frank Kung